Literature DB >> 20309574

Association between macular microcirculation and soluble intercellular adhesion molecule-1 in patients with macular edema and retinal vein occlusion.

Hidetaka Noma1, Hideharu Funatsu, Kumi Sakata, Tatsuya Mimura, Sadao Hori.   

Abstract

BACKGROUND: In patients who have macular edema secondary to retinal vein occlusion, the role of vasoactive molecules such as growth factors and the influence of molecules related to leukocyte adhesion need to be investigated further.
METHODS: A prospective study was performed to investigate the relations between perifoveal capillary blood flow velocity and the vitreous levels of vascular endothelial growth factor (VEGF) and soluble intercellular adhesion molecule-1 (sICAM-1) in patients with macular edema and retinal vein occlusion. Undiluted vitreous specimens were obtained from 11 eyes of 11 patients with macular edema (nine had branch retinal vein occlusion and two had central retinal vein occlusion). VEGF and sICAM-1 levels were measured by enzyme-linked immunoabsorbent assay. Before vitreous sampling, perifoveal capillary blood flow velocity was measured by fluorescein angiography with a scanning laser ophthalmoscope and the tracing method. The relations between perifoveal capillary blood flow velocity and the vitreous levels of VEGF and sICAM-1 were investigated.
RESULTS: There was a significant correlation between perifoveal capillary blood flow velocity and the vitreous level of sICAM-1 (rho = -0.7303, p = 0.03). In contrast, there was no significant association between blood flow velocity and the vitreous level of VEGF (rho = -0.1458, p = 0.67).
CONCLUSIONS: The vitreous level of sICAM-1 is associated with perifoveal capillary blood flow velocity in patients who have retinal vein occlusion and macular edema.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20309574     DOI: 10.1007/s00417-010-1350-9

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  10 in total

1.  Retinal artery response to acute systemic blood pressure increase during cold pressor test in humans.

Authors:  Taiji Nagaoka; Fumihiko Mori; Akitoshi Yoshida
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-06       Impact factor: 4.799

2.  Macular microcirculation and macular oedema in branch retinal vein occlusion.

Authors:  H Noma; H Funatsu; K Sakata; S Harino; T Nagaoka; T Mimura; T Sone; S Hori
Journal:  Br J Ophthalmol       Date:  2009-02-10       Impact factor: 4.638

3.  VEGF increases retinal vascular ICAM-1 expression in vivo.

Authors:  M Lu; V L Perez; N Ma; K Miyamoto; H B Peng; J K Liao; A P Adamis
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-07       Impact factor: 4.799

4.  Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition.

Authors:  K Miyamoto; S Khosrof; S E Bursell; R Rohan; T Murata; A C Clermont; L P Aiello; Y Ogura; A P Adamis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

5.  In vivo evaluation of leukocyte dynamics in retinal ischemia reperfusion injury.

Authors:  A Tsujikawa; Y Ogura; N Hiroshiba; K Miyamoto; J Kiryu; Y Honda
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-04       Impact factor: 4.799

6.  Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema.

Authors:  Hideharu Funatsu; Hidetoshi Yamashita; Kumi Sakata; Hidetaka Noma; Tatsuya Mimura; Motohiro Suzuki; Shuichiro Eguchi; Sadao Hori
Journal:  Ophthalmology       Date:  2005-05       Impact factor: 12.079

7.  Modulation and function of intercellular adhesion molecule-1 (CD54) on human retinal pigment epithelial cells.

Authors:  S G Elner; V M Elner; M A Pavilack; R F Todd; L Mayo-Bond; W A Franklin; R M Strieter; S L Kunkel; A R Huber
Journal:  Lab Invest       Date:  1992-02       Impact factor: 5.662

8.  Macular microcirculation in hypertensive patients with and without branch retinal vein occlusion.

Authors:  Hidetaka Noma; Hideharu Funatsu; Kumi Sakata; Seiyo Harino; Tatsuya Mimura; Sadao Hori
Journal:  Acta Ophthalmol       Date:  2008-07-08       Impact factor: 3.761

9.  Quantification of retinal capillary density and flow velocity in patients with essential hypertension.

Authors:  S Wolf; O Arend; K Schulte; T H Ittel; M Reim
Journal:  Hypertension       Date:  1994-04       Impact factor: 10.190

10.  Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab.

Authors:  Marion Funk; Katharina Kriechbaum; Franz Prager; Thomas Benesch; Michael Georgopoulos; Gerhard J Zlabinger; Ursula Schmidt-Erfurth
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-05       Impact factor: 4.799

  10 in total
  4 in total

1.  Pigment epithelium-derived factor is related to macular microcirculation in patients with macular edema and branch retinal vein occlusion.

Authors:  Hidetaka Noma; Hideharu Funatsu; Tatsuya Mimura
Journal:  Int Ophthalmol       Date:  2012-05-19       Impact factor: 2.031

2.  Aqueous humour concentrations of TGF-β, PLGF and FGF-1 and total retinal blood flow in patients with early non-proliferative diabetic retinopathy.

Authors:  Lee-Anne Khuu; Faryan Tayyari; Jeremy M Sivak; John G Flanagan; Shaun Singer; Michael H Brent; David Huang; Ou Tan; Christopher Hudson
Journal:  Acta Ophthalmol       Date:  2016-09-28       Impact factor: 3.761

Review 3.  Cytokines and the Pathogenesis of Macular Edema in Branch Retinal Vein Occlusion.

Authors:  Hidetaka Noma; Kanako Yasuda; Masahiko Shimura
Journal:  J Ophthalmol       Date:  2019-05-02       Impact factor: 1.909

Review 4.  A Review of Intraocular Biomolecules in Retinal Vein Occlusion: Toward Potential Biomarkers for Companion Diagnostics.

Authors:  Bingjie Wang; Xiao Zhang; Huan Chen; Adrian Koh; Chan Zhao; Youxin Chen
Journal:  Front Pharmacol       Date:  2022-04-26       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.